Torisson Gustav, Bruun Madsen Martin, Schmidt Davidsen Agnes, Perner Anders, Lipman Jeffrey, Dulhunty Joel, Sjövall Fredrik
Department of Infectious Diseases, Skane University Hospital, Malmö, Sweden.
Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Crit Care Explor. 2021 May 12;3(5):e0383. doi: 10.1097/CCE.0000000000000383. eCollection 2021 May.
To explore the association between antibiotic combination therapy and in-hospital mortality in patients with septic shock in two tertiary ICUs in different countries.
Retrospective observational study.
ICUs of two tertiary hospitals, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia, and Rigshospitalet, Copenhagen, Denmark.
Adult patients with antibiotic treatment greater than or equal to 72 hours and vasopressor therapy greater than or equal to 24 hours.
Combination versus mono antibiotic therapy.
Combination antibiotic therapy was defined as receiving two or more antibiotics from different classes, started within 12 hours of each other and with an overlapping duration of greater than or equal to 12 hours. Bivariate and multiple logistic regression analysis were performed comparing combination antibiotic therapy versus antibiotic monotherapy on in-hospital mortality. The analysis was adjusted for age, gender, centre, Acute Physiology and Chronic Health Evaluation II score, and chronic health evaluation. In total, 1,667 patients were included with 953 (57%) receiving combination therapy. Patients given combination therapy were older (60 ± 16 vs 56 ± 18), more likely admitted to Rigshospitalet (58% vs 16%), and had a higher Acute Physiology and Chronic Health Evaluation II score (26 ± 8 vs 23 ± 8). Combination therapy was associated with an increased mortality in univariate analysis (odds ratio = 1.33; 95% CI, 1.07-1.66); however, there was no significant association in the adjusted analysis (odds ratio = 0.88; 95% CI, 0.68-1.15).
In this retrospective study, no association was found between use of combination therapy and in-hospital mortality. The large differences between centers probably reflect local traditions and lack of definitive evidence.
探讨不同国家两家三级重症监护病房(ICU)中,脓毒性休克患者接受抗生素联合治疗与院内死亡率之间的关联。
回顾性观察研究。
澳大利亚昆士兰州布里斯班皇家布里斯班妇女医院和丹麦哥本哈根里格霍斯医院这两家三级医院的ICU。
接受抗生素治疗≥72小时且血管活性药物治疗≥24小时的成年患者。
联合抗生素治疗与单一抗生素治疗。
联合抗生素治疗定义为在12小时内先后使用两种或更多不同种类抗生素,且重叠使用时间≥12小时。采用双变量和多因素逻辑回归分析,比较联合抗生素治疗与单一抗生素治疗对院内死亡率的影响。分析对年龄、性别、中心、急性生理与慢性健康状况评分系统II(APACHE II)评分以及慢性健康评估进行了校正。总共纳入1667例患者,其中953例(57%)接受联合治疗。接受联合治疗的患者年龄更大(60±16岁 vs 56±18岁),更有可能入住里格霍斯医院(58% vs 16%),且急性生理与慢性健康状况评分系统II评分更高(26±8分 vs 23±8分)。在单因素分析中,联合治疗与死亡率增加相关(比值比=1.33;95%置信区间,1.07 - 1.66);然而,在校正分析中无显著关联(比值比=0.88;95%置信区间,0.68 - 1.15)。
在这项回顾性研究中,未发现联合治疗的使用与院内死亡率之间存在关联。各中心之间的巨大差异可能反映了当地传统且缺乏确凿证据。